Clinical experience with ibenzmethyzin (Natulan) in the treatment of lymphomas and solid tumours.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000568:Amenorrhea / Q000139:chemically induced; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003348:Cortisone / Q000627:therapeutic use; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D006834:Hydrazines / Q000009:adverse effects / Q000627:therapeutic use*; D007970:Leukopenia / Q000139:chemically induced; D008197:Lymph Node Excision; D008223:Lymphoma / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000188:drug therapy; D013921:Thrombocytopenia / Q000139:chemically induced
D000970:Antineoplastic Agents; D006834:Hydrazines; D003348:Cortisone